Longeveron (LGVN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Longeveron (LGVN) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.00 of bullish evidence against -0.50 bearish.

Longeveron last closed at $2.48, +4.64% on the session.

Against the IVW growth benchmark the position is +3.84% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for LGVN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Longeveron in the 4th percentile on return on equity, where 100 is best.

Longeveron is classified under Health Care / Biotechnology, with a market capitalisation of $7.56M.

StockMap tracks Longeveron as the 361st largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Longeveron ranks 372nd of 381 in the group, against a group median of -0.08.